Prevention of HIV infection among injection drug users in resource-limited settings

David Vlahov, Angela M. Robertson, Steffanie A. Strathdee

    Research output: Contribution to journalReview article

    Abstract

    Injection drug use contributes to considerable global morbidity and mortality associated with human immunodeficiency virus (HIV) infection and AIDS and other infections due to blood-borne pathogens through the direct sharing of needles, syringes, and other injection equipment. Of ∼16 million injection drug users (IDUs) worldwide, an estimated 3 million are HIV infected. The prevalence of HIV infection among IDUs is high in many countries in Asia and eastern Europe and could exacerbate the HIV epidemic in sub-Saharan Africa. This review summarizes important components of a comprehensive program for prevention of HIV infection in IDUs, including unrestricted legal access to sterile syringes through needle exchange programs and enhanced pharmacy services, treatment for opioid dependence (ie, methadone and buprenorphine treatment), behavioral interventions, and identification and treatment of noninjection drug and alcohol use, which accounts for increased sexual transmission of HIV. Evidence supports the effectiveness of harm-reduction programs over punitive drug-control policies.

    Original languageEnglish (US)
    Pages (from-to)S114-S121
    JournalClinical Infectious Diseases
    Volume50
    Issue numberSUPPL. 3
    DOIs
    StatePublished - May 15 2010

    ASJC Scopus subject areas

    • Microbiology (medical)
    • Infectious Diseases

    Fingerprint Dive into the research topics of 'Prevention of HIV infection among injection drug users in resource-limited settings'. Together they form a unique fingerprint.

  • Cite this